Paclitaxel-Eluting Stent Versus Sirolimus-Eluting Stent for the Prevention of Restenosis in Diabetic Patients With Coronary Artery Disease - ISAR DIABETES

Description:

The goal of the trial was to evaluate treatment with paclitaxel-eluting stents compared with sirolimus-eluting stents among diabetic patients with coronary artery disease.